Current Clinical Trials

Craniopharyngioma (World Health Organization grade I) is often curable. (Refer to the Tumors of the Sellar Region ¹ section in the Classification ² section of this summary for more information.)

Standard treatment options:

1. Surgery alone if the tumor is totally resectable.[1]
2. Debulking surgery plus radiation therapy if the tumor is unresectable.[2]

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with adult craniopharyngioma ³. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site ⁴.

References

1. Baskin DS, Wilson CB: Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg 65 (1): 22-7, 1986.  [PUBMED Abstract]
   
   
2. Rajan B, Ashley S, Gorman C, et al.: Craniopharyngioma--a long-term results following limited surgery and radiotherapy. Radiother Oncol 26 (1): 1-10, 1993.  [PUBMED Abstract]